Preparation of saxagliptin, a novel DPP-IV inhibitor

Organic Process Research and Development

Volumn 13, Issue 6, 2009, Pages 1169-1176

  Savage, Scott A ^a   Jones, Gregory S ^a   Kolotuchin, Sergei ^a   Ramrattan, Shelly Ann ^a   Vu, Truc ^a   Waltermire, Robert E ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 72449123195     PISSN: 10836160     EISSN: 1520586X     Source Type: Journal    
DOI: 10.1021/op900226j     Document Type: Article

References (29)

1. Wild, S.; Roglic, G.; Green, A.; Sicree, R.; King, H. Diabetes Care 2004, 27, 1047-1053.
2. (a) Idris, I; Donnelly, R. Diabetes, Obes. Metab. 2007, 9, 153-165.
3. (b) von Geldern, T. W.; Trevillyan, J. M. Drug Dev. Res. 2006, 67, 627-642.
4. FDA News Release P06-169, 2006.
5. Langley, A. K.; Suffoletta, T. J.; Jennings, H. R. Pharmacotherapy 2007, 27, 1163-1180.
6. (a) Augeri, D. J.; Robl, J. A.; Betebenner, D. A.; Magnin, D. R.; Khanna, A.; Robertson, J. G.; Wang, A.; Simpkins, L. M.; Taunk, P.; Huang, Q.; Han, S.-P.; Abboa-Offei, B.; Cap, M.; Xin, L.; Tao, L.; Tozzo, E.; Welzel, G. E.; Egan, D. M.; Marcinkeviciene, J.; Chang, S. Y.; Biller, S. A.; Kirby, M. S.; Parker, R. A.; Hammann, L. G. J. Med. Chem. 2005, 48, 5025-5037.
7. (b) Bristol-Myers Squibb and Astra Zeneca News Release, July 31st, 2009.
8. (a) Vu, T. C.; Brzozowski, D. B.; Fox, R.; Godfrey, J. D.; Hanson, R. L.; Kolotuchin, S. V.; Mazzullo, J. A.; Patel, R. N.; Wang, J.; Wong, K.; Yu, J.; Zhu, J.; Magnin, D. R.; Augeri, D. J.; Hamann, L. G. Methods and Compounds Producing Dipeptidyl Petidase IV Inhibitors and Intermediates Thereof. Int. Pub. Num. WO2004052850, 2004.
9. (b) Hanson, R. L.; Goldberg, S. L.; Brzozowski, D. B.; Tully, T. P.; Cazzulino, D.; Parker, W. L.; Lyngberg, O. K.; Vu, T. C.; Wong, M. K.; Patel, R. N. Adv. Synth. Catal. 2007, 349, 1369-1378.
10. Montalbetti, C. A. G. N.; Falque, V. Tetrahedron 2005, 61, 10827-10852.
11. Glowienke, S.; Frieauff, W.; Allmendinger, T.; Martus, H.; Suter, W.; Mueller, L. Mutat. Res. 2005, 581, 23-24.
12. The combined mother liquor and cake washes had <1000 ppm of IPMS on scale.
13. Lab-scale gas evolution studies showed that no significant gas was evolved until after ∼15% of the MSA was added and that, if the MSA addition was spread over 1 h or longer, ∼90% of the reaction would occur during the acid charge. This allowed a high level of control over the evolution of carbon dioxide and isobutylene.
14. Carey, J. S.; Laffan, D.; Thomson, C.; Williams, M. T. Org. Biol. Chem. 2006, 4, 2337-2347.
15. 3-DMF, 2-chloro-4,6-dimethoxy-1,3,5-triazine, N,N2 -carbonyldiimidazole. Specifically, mixed anhydrides suffered from nonselective reactivity with amine 4.
16. While kilogram quantities typically cost ∼$2000/kg, manufacturingscale quantities typically run an order of magnitude less at $100 to $200 per kg.
17. Dunn, P. J.; Hoffmann, W.; Kang, Y.; Mitchell, J. C.; Snowden, M. J. Org. Process Res. Dev. 2005, 9, 956-961.
18. Potassium bicarbonate allowed for higher concentrations of salts than sodium bicarbonate and therefore reduced product loss to the aqueous layer. Though potassium carbonate washes were also effective, they were not chosen to avoid the possibility of epimerization during the subsequent distillation.
19. Anthoni, U.; Christensen, D.; Christophersen, C.; Nielsen, P. H. Acta Chem. Scand. 1995, 49, 203-6.
20. Schreiber, S. L. Tetrahedron Lett. 1980, 21, 1027.
21. Kiwase, M.; Teshima, M.; Saito, S.; Tani, S. Heterocycles 1998, 48, 2103.
22. Clark, J. H.; Emsley, J. J. Chem. Soc., Dalton Trans. 1974, 11, 1125-9.
23. LD 50: >2005 mg/kg (rat), cutaneous irritation: nonirritant (rabbit), ocular irritation: nonirritant (rabbit). See the MSDS at Seppic (Seppic, Inc., Fairfield, NJ).
24. Epimerization of the nitrile stereogenic center was observed at pH >12 under warm, alcoholic conditions.
25. The water solubility of the monohydrate is 19 mg/mL.
26. Gentilcore, M. J. Chem. Eng. Proc. 2002, 56-59.
27. (a) Cypes, S. H.; Wenslow, R. M.; Thomas, S. M.; Chen, A. M.; Dorwart, J. G.; Corte, J. R.; Kaba, M. Org. Process Res. Dev. 2004, 8, 576-582.
28. (b) Variankaval, N.; Lee, C.; Xu, J; Calabria, R.; Tsou, N.; Ball, R. Org. Process Res. Dev. 2007, 11, 229-236.
29. Horsley, L. H. Azeotropic Data III; Advances in Chemistry Series, 116, American Chemical Society: Washington D.C., 1973; p 21.